Nadolol: Difference between revisions

Nadolol
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 11:32, 23 March 2025

Beta blocker medication

Nadolol is a non-selective beta blocker used in the treatment of hypertension and angina pectoris. It is also used in the management of certain types of arrhythmias and for the prevention of migraine headaches. Nadolol is known for its long duration of action, which allows for once-daily dosing.

Pharmacology[edit]

Nadolol works by blocking the action of epinephrine and norepinephrine on beta-adrenergic receptors, which are part of the sympathetic nervous system. This action results in a decrease in heart rate, cardiac output, and blood pressure. Nadolol is non-selective, meaning it blocks both beta-1 and beta-2 adrenergic receptors.

Medical uses[edit]

Nadolol is primarily used to treat:

Hypertension
Angina pectoris
Certain types of arrhythmias
Prevention of migraine headaches

Hypertension[edit]

Nadolol is effective in lowering blood pressure by reducing cardiac output and inhibiting the release of renin from the kidneys. It is often used in combination with other antihypertensive agents for better control of blood pressure.

Angina pectoris[edit]

In patients with angina, nadolol reduces the frequency and severity of angina attacks by decreasing myocardial oxygen demand through its effects on heart rate and contractility.

Arrhythmias[edit]

Nadolol is used in the management of certain arrhythmias, particularly those that are exacerbated by sympathetic stimulation.

Migraine prevention[edit]

Nadolol is sometimes used off-label for the prevention of migraine headaches, as it can reduce the frequency and severity of attacks.

Side effects[edit]

Common side effects of nadolol include:

Serious side effects may include:

Contraindications[edit]

Nadolol should not be used in patients with:

Asthma or chronic obstructive pulmonary disease (COPD)
Bradycardia
Heart block
Cardiogenic shock

Mechanism of action[edit]

Nadolol blocks beta-adrenergic receptors, which are involved in the "fight or flight" response. By blocking these receptors, nadolol reduces the effects of stress hormones like epinephrine, leading to a decrease in heart rate and blood pressure.

Pharmacokinetics[edit]

Nadolol is well absorbed from the gastrointestinal tract, but it has a low bioavailability due to first-pass metabolism. It is not metabolized by the liver and is excreted unchanged in the urine. The half-life of nadolol is approximately 20 to 24 hours, allowing for once-daily dosing.

Related pages[edit]

@@ Line 1: / Line 1: @@
-{{intro}}
+{{Short description|Beta blocker medication}}
-Nadolol is a nonselective beta-adrenergic receptor blocker that is widely used for the therapy of [[hypertension]], angina pectoris and vascular [[headaches]].
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Nadolol.svg
+| image2 = Nadolol_Structural_Formulae.svg
+}}
-{{livtox}}
+'''Nadolol''' is a non-selective [[beta blocker]] used in the treatment of [[hypertension]] and [[angina pectoris]]. It is also used in the management of certain types of [[arrhythmias]] and for the prevention of [[migraine]] headaches. Nadolol is known for its long duration of action, which allows for once-daily dosing.
-Nadolol has yet to be convincingly associated with clinically apparent liver injury.
-{{moa}}
+==Pharmacology==
-Nadolol (nay' doe lol) was the second beta-blocker developed for therapy of [[hypertension]] and is considered nonselective, acting on both the beta-1 and beta-2 adrenergic receptors. Beta-1 adrenergic blockade reduces the heart rate and myocardial contractility by slowing the atrioventricular (AV) conduction and suppressing automaticity. Beta-2 blockade affects peripheral vascular resistance and can cause bronchospasm and hypoglycemia. The beta-2 blockade is responsible for the majority of adverse effects associated with nadolol.
+Nadolol works by blocking the action of [[epinephrine]] and [[norepinephrine]] on beta-adrenergic receptors, which are part of the [[sympathetic nervous system]]. This action results in a decrease in heart rate, cardiac output, and blood pressure. Nadolol is non-selective, meaning it blocks both beta-1 and beta-2 adrenergic receptors.
-{{fda}}
+==Medical uses==
-Nadolol was approved for use in the United States in 1979 and is still commonly used, with more than 1 million prescriptions filled yearly. Nadolol is indicated for the management of [[hypertension]] and angina pectoris, and is used off label for prophylaxis against migraine and vascular [[headaches]].
+Nadolol is primarily used to treat:
+* [[Hypertension]]
+* [[Angina pectoris]]
+* Certain types of [[arrhythmias]]
+* Prevention of [[migraine]] headaches
-{{dose}}
+===Hypertension===
-Nadolol is available in multiple generic forms and under the trade name of Corgard in tablets of 20, 40, 80, 120 and 160 mg. Fixed combinations with diuretics are also available (nadolol and bendroflumethiazide: Corzide). The typical dose of nadolol in adults is 40 to 80 mg once daily.
+Nadolol is effective in lowering blood pressure by reducing cardiac output and inhibiting the release of [[renin]] from the kidneys. It is often used in combination with other antihypertensive agents for better control of blood pressure.
-{{se}}
+===Angina pectoris===
-Common side effects of nadolol include [[bradycardia]], hypotension, [[fatigue]], [[dizziness]], [[depression]], memory loss, [[incontinence]], cold limbs and, less commonly, severe hypotension, [[heart failure]] and bronchospasm. Sudden withdrawal can trigger rebound [[hypertension]]. Beta-blockers are contraindicated in patients with asthma, [[bradycardia]] and [[heart failure]], and should be used cautiously in the elderly and in patients with diabetes.
+In patients with angina, nadolol reduces the frequency and severity of angina attacks by decreasing myocardial oxygen demand through its effects on heart rate and contractility.
-{{beta blockers}}
+===Arrhythmias===
-{{antihypertensives}}
+Nadolol is used in the management of certain arrhythmias, particularly those that are exacerbated by sympathetic stimulation.
-{{coststubd}}
+===Migraine prevention===
+Nadolol is sometimes used off-label for the prevention of migraine headaches, as it can reduce the frequency and severity of attacks.
+==Side effects==
+Common side effects of nadolol include:
+* [[Bradycardia]]
+* [[Fatigue]]
+* [[Dizziness]]
+* [[Cold extremities]]
+* [[Gastrointestinal disturbances]]
+Serious side effects may include:
+* [[Bronchospasm]]
+* [[Heart failure]]
+* [[Hypotension]]
+==Contraindications==
+Nadolol should not be used in patients with:
+* [[Asthma]] or [[chronic obstructive pulmonary disease]] (COPD)
+* [[Bradycardia]]
+* [[Heart block]]
+* [[Cardiogenic shock]]
+==Mechanism of action==
+Nadolol blocks beta-adrenergic receptors, which are involved in the "fight or flight" response. By blocking these receptors, nadolol reduces the effects of stress hormones like epinephrine, leading to a decrease in heart rate and blood pressure.
+==Pharmacokinetics==
+Nadolol is well absorbed from the gastrointestinal tract, but it has a low bioavailability due to first-pass metabolism. It is not metabolized by the liver and is excreted unchanged in the urine. The half-life of nadolol is approximately 20 to 24 hours, allowing for once-daily dosing.
+==Related pages==
+* [[Beta blocker]]
+* [[Hypertension]]
+* [[Angina pectoris]]
+* [[Arrhythmia]]
+* [[Migraine]]
+[[Category:Beta blockers]]
+[[Category:Antihypertensive agents]]
+[[Category:Antianginal agents]]